Zomedica Corp. (ZOMDF) income statement
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica Corp. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 65.4%
- Operating margin
- -56.3%
- Net margin
- -51.4%
- Return on equity, FY2025
- -52.6%
Financial strength
- Current ratio
- 6.43
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 79.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.10
- Price to book
- 0.72
- Dividend yield
- –
See a number that looks wrong?